venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $194,334 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 40.9%

Value ($000) $79,438 Shares 4,289,304 Est. Cost $21.15 Unrealized -13.6%

ALMS ALUMIS INC 15.5%

Value ($000) $30,182 Shares 2,826,048 Est. Cost $13.30 Unrealized -8.8%

HRMY HARMONY BIOSCIENCES HLDGS IN 12.7%

Value ($000) $24,584 Shares 614,594 Est. Cost $36.46 Unrealized -3.7%

ARTV ARTIVA BIOTHERAPEUTICS INC 12.1%

Value ($000) $23,484 Shares 1,519,971 Est. Cost $11.59 Unrealized 0.0%

— ACELYRIN INC 9.8%

Value ($000) $18,993 Shares 3,852,470 Est. Cost $20.90 Unrealized —

ALXO ALX ONCOLOGY HLDGS INC 9.1%

Value ($000) $17,654 Shares 9,699,925 Est. Cost $39.31 Unrealized -90.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,289,304	$79,438	40.9%	$21.15	-13.6%	COM	N69605108
ALMS	ALUMIS INC	2,826,048	$30,182	15.5%	$13.30	-8.8%	COM	022307102
HRMY	HARMONY BIOSCIENCES HLDGS IN	614,594	$24,584	12.7%	$36.46	-3.7%	COM	413197104
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,519,971	$23,484	12.1%	$11.59	0.0%	COM	04317A107
—	ACELYRIN INC	3,852,470	$18,993	9.8%	$20.90	—	COM	00445A100
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$17,654	9.1%	$39.31	-90.5%	COM	00166B105